Development of innovative injectable pharmaceuticals for emergency and resuscitation, anesthesia, and neurology.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
IDMED
B
Development and commercialization of innovative medical devices for anesthesia and intensive care.
Medincell
A
Development of innovative pharmaceutical and biotechnology products, focusing on advanced drug delivery systems.
Laboratoire Aguettant
A
Specialized in essential hospital injectable drugs and ready-to-use medicines, focusing on patient safety and therapeutic solutions for hospitals.
Initiatives identified among leaders
Participer au développement des Objectifs de Développement Durable
“Medincell participe au développement des Objectifs...” - MedincellRéduction des émissions de gaz à effet de serre
“Laboratoire Aguettant a réduit ses émissions de ga...” - Laboratoire AguettantSélectionner des fournisseurs responsables
“IDMED sélectionne des fournisseurs responsables en...” - IDMED61% of similar organizations communicate on CSR issues
+4526 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports